OTC Labeling Reg Inapplicable To Professional-Use Kits - Becton Dickinson
This article was originally published in The Tan Sheet
Executive Summary
FDA's OTC labeling rules should not apply to blood culture "convenience" kits containing OTC drug components used by health care professionals, Becton, Dickinson & Co. asserts.
You may also be interested in...
Bactec Kit Outer Labeling Only Required To Comply With “Drug Facts” Format
The individual OTC components in Becton Dickinson's Bactec Blood Culture Procedural Tray will not be required to carry "Drug Facts" labeling as long as the kit's outer package uses the OTC labeling format to describe the components, FDA says in a June 5 letter to the firm
Thursday Plantation
Australia-based tea tree manufacturer requests exemption from OTC labeling final rule for 2 oz. 100% Pure Tea Tree Oil, saying compliance is "impracticable" because "label size is too small to fit bar lines and all the wording in the font size required." Moreover, "should the font size be decreased, the letters bleed slightly, which may cause deterioration of text legibility," company maintains in March 23 letter to FDA. Antiseptic is sold in health food stores worldwide under Thursday Plantation brand
OTC Labeling Exemption, Deferral Timelines Depend On Complexity - FDA
FDA expects to respond to completed OTC labeling exemption and deferral requests that are straightforward or "consistent with previously granted requests" in 30 to 60 days, the agency says.